ID

14142

Description

Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01520818

Lien

https://clinicaltrials.gov/show/NCT01520818

Mots-clés

  1. 31/03/2016 31/03/2016 -
Téléchargé le

31 mars 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes NCT01520818

Eligibility Diabetes NCT01520818

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01520818
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 1 or type 2 diabetes
Description

Type 1 or type 2 diabetes

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0011860
current treatment with bhi 30 twice daily as the only insulin therapy for at least 3 months, with or without combination with oral hypoglycaemic agents
Description

Biphasic human insulin and insulin regime

Type de données

boolean

Alias
UMLS CUI [1,1]
C1562202
UMLS CUI [1,2]
C0557978
body mass index (bmi) maximum 40.0 kg/m^2
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of drug or alcohol dependence
Description

Substance use disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
impaired hepatic function
Description

Hepatic function

Type de données

boolean

Alias
UMLS CUI [1]
C0232741
impaired renal function
Description

Renal function

Type de données

boolean

Alias
UMLS CUI [1]
C0232804
cardiac disease
Description

Cardiac disease

Type de données

boolean

Alias
UMLS CUI [1]
C0018799
proliferative retinopathy
Description

Proliferative retinopathy

Type de données

boolean

Alias
UMLS CUI [1]
C0339467
total daily insulin dose at least 1.80 iu/kg
Description

daily insulin dose

Type de données

boolean

Alias
UMLS CUI [1,1]
C2348070
UMLS CUI [1,2]
C0557978

Similar models

Eligibility Diabetes NCT01520818

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01520818
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Type 1 or type 2 diabetes
Item
type 1 or type 2 diabetes
boolean
C0011854 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Biphasic human insulin and insulin regime
Item
current treatment with bhi 30 twice daily as the only insulin therapy for at least 3 months, with or without combination with oral hypoglycaemic agents
boolean
C1562202 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
Body mass index
Item
body mass index (bmi) maximum 40.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Substance use disorder
Item
history of drug or alcohol dependence
boolean
C0038586 (UMLS CUI [1])
Hepatic function
Item
impaired hepatic function
boolean
C0232741 (UMLS CUI [1])
Renal function
Item
impaired renal function
boolean
C0232804 (UMLS CUI [1])
Cardiac disease
Item
cardiac disease
boolean
C0018799 (UMLS CUI [1])
Proliferative retinopathy
Item
proliferative retinopathy
boolean
C0339467 (UMLS CUI [1])
daily insulin dose
Item
total daily insulin dose at least 1.80 iu/kg
boolean
C2348070 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial